| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Australia | 5 | |
| #3 | Canada | 5 | |
| #4 | Israel | 4 | |
| #5 | China | 3 | |
| #6 | EPO (European Patent Office) | 3 | |
| #7 | Republic of Korea | 3 | |
| #8 | Singapore | 3 | |
| #9 | United States | 3 | |
| #10 | Brazil | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Yunyun | 31 |
| #2 | Guo Yanan | 31 |
| #3 | Ni Jian | 31 |
| #4 | Shen Yuelei | 31 |
| #5 | Xie Jingshu | 31 |
| #6 | Yang Fang | 31 |
| #7 | Yang Yi | 31 |
| #8 | Dong Chunyan | 30 |
| #9 | Lu Chengyuan | 30 |
| #10 | Cheng Xiaodong | 22 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020253722A1 | Anti-cd40 antibodies and uses thereof | |
| WO2020052581A1 | Anti-tnfrsf9 antibodies and uses thereof | |
| SG11202100510PA | Anti-cd40 antibodies and uses thereof | |
| EP3755716A1 | Anti-pd-1 antibodies and uses thereof | |
| EP3713958A1 | Anti-ox40 antibodies and uses thereof | |
| CA3073984A1 | Anti-ctla4 antibodies and uses thereof |